CAB39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.643400E-01
Normal-vs-Stage2
8.393000E-01
Normal-vs-Stage3
3.491400E-01
Normal-vs-Stage4
4.624400E-01
Stage1-vs-Stage2
2.783000E-01
Stage1-vs-Stage3
6.404000E-01
Stage1-vs-Stage4
1.441440E-01
Stage2-vs-Stage3
1.825410E-01
Stage2-vs-Stage4
4.966800E-01
Stage3-vs-Stage4
1.487240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.929200E-01
Normal-vs-AfricanAmerican
6.433800E-01
Normal-vs-Asian
8.341600E-01
Caucasian-vs-AfricanAmerican
5.030000E-01
Caucasian-vs-Asian
5.842400E-01
AfricanAmerican-vs-Asian
6.501400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.752400E-01
Normal-vs-Female
9.254600E-01
Male-vs-Female
8.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.214600E-01
Normal-vs-Age(41-60Yrs)
5.299600E-01
Normal-vs-Age(61-80Yrs)
7.736200E-01
Normal-vs-Age(81-100Yrs)
6.705200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.619800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.031400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.480600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.636520E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.257840E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.401800E-01
Normal-vs-Daily Drinker
6.590200E-01
Normal-vs-Weekly Drinker
9.445400E-01
Normal-vs-Occasional Drinker
5.719600E-01
Normal-vs-Social Drinker
6.694600E-01
Non Drinker-vs-Daily Drinker
3.369400E-01
Non Drinker-vs-Weekly Drinker
7.993800E-01
Non Drinker-vs-Occasional Drinker
4.323800E-01
Non Drinker-vs-Social Drinker
4.309000E-01
Daily Drinker-vs-Weekly Drinker
5.239800E-01
Daily Drinker-vs-Occasional Drinker
6.296000E-02
Daily Drinker-vs-Social Drinker
7.689600E-01
Weekly Drinker-vs-Occasional Drinker
2.917000E-01
Weekly Drinker-vs-Social Drinker
6.763200E-01
Occasional Drinker-vs-Social Drinker
9.474100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.158200E-01
Normal-vs-Grade 2
9.978100E-03
Normal-vs-Grade 3
1.757650E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.395970E-02
Grade 1-vs-Grade 3
5.100200E-03
Grade 1-vs-Grade 4
2.158200E-01
Grade 2-vs-Grade 3
4.465800E-01
Grade 2-vs-Grade 4
9.978100E-03
Grade 3-vs-Grade 4
1.757650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.209800E-01
Normal-vs-NonDiabetic
9.982000E-01
Diabetic-vs-NonDiabetic
4.915000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.536200E-01
Normal-vs-NoPancreatitis
9.877200E-01
Pancreatitis-vs-NoPancreatitis
7.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.451800E-01
Normal-vs-N1
8.266200E-01
N0-vs-N1
5.462100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.851600E-01
Normal-vs-TP53-NonMutant
6.300600E-01
TP53-Mutant-vs-TP53-NonMutant
1.009690E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
